Back to Search
Start Over
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
- Source :
- American Journal of Physiology-Cell Physiology. 296:C1258-C1270
- Publication Year :
- 2009
- Publisher :
- American Physiological Society, 2009.
-
Abstract
- Myostatin is a negative regulator of skeletal muscle size, previously shown to inhibit muscle cell differentiation. Myostatin requires both Smad2 and Smad3 downstream of the activin receptor II (ActRII)/activin receptor-like kinase (ALK) receptor complex. Other transforming growth factor-β (TGF-β)-like molecules can also block differentiation, including TGF-β1, growth differentiation factor 11 (GDF-11), activins, bone morphogenetic protein 2 (BMP-2) and BMP-7. Myostatin inhibits activation of the Akt/mammalian target of rapamycin (mTOR)/p70S6 protein synthesis pathway, which mediates both differentiation in myoblasts and hypertrophy in myotubes. Blockade of the Akt/mTOR pathway, using small interfering RNA to regulatory-associated protein of mTOR (RAPTOR), a component of TOR signaling complex 1 (TORC1), increases myostatin-induced phosphorylation of Smad2, establishing a myostatin signaling-amplification role for blockade of Akt. Blockade of RAPTOR also facilitates myostatin's inhibition of muscle differentiation. Inhibition of TORC2, via rapamycin-insensitive companion of mTOR (RICTOR), is sufficient to inhibit differentiation on its own. Furthermore, myostatin decreases the diameter of postdifferentiated myotubes. However, rather than causing upregulation of the E3 ubiquitin ligases muscle RING-finger 1 ( MuRF1) and muscle atrophy F-box ( MAFbx), previously shown to mediate skeletal muscle atrophy, myostatin decreases expression of these atrophy markers in differentiated myotubes, as well as other genes normally upregulated during differentiation. These findings demonstrate that myostatin signaling acts by blocking genes induced during differentiation, even in a myotube, as opposed to activating the distinct “atrophy program.” In vivo, inhibition of myostatin increases muscle creatine kinase activity, coincident with an increase in muscle size, demonstrating that this in vitro differentiation measure is also upregulated in vivo.
- Subjects :
- Follistatin
Physiology
Muscle Fibers, Skeletal
Muscle Proteins
Mice, SCID
Smad2 Protein
Myostatin
Tripartite Motif Proteins
Mice
Myocyte
Insulin-Like Growth Factor I
Phosphorylation
RNA, Small Interfering
Creatine Kinase
Cells, Cultured
Muscle cell differentiation
TOR Serine-Threonine Kinases
Ribosomal Protein S6 Kinases, 70-kDa
Cell Differentiation
Organ Size
Activin receptor
musculoskeletal system
Cell biology
medicine.anatomical_structure
Benzamides
RNA Interference
Signal transduction
Signal Transduction
medicine.medical_specialty
Myoblasts, Skeletal
Ubiquitin-Protein Ligases
Dioxoles
Biology
Transfection
Internal medicine
medicine
Animals
Humans
Smad3 Protein
Protein Kinase Inhibitors
Protein kinase B
Adaptor Proteins, Signal Transducing
Cell Size
SKP Cullin F-Box Protein Ligases
Proteins
Skeletal muscle
Regulatory-Associated Protein of mTOR
Cell Biology
Rapamycin-Insensitive Companion of mTOR Protein
Endocrinology
GDF11
biology.protein
Carrier Proteins
Activin Receptors, Type I
Protein Kinases
Proto-Oncogene Proteins c-akt
Subjects
Details
- ISSN :
- 15221563 and 03636143
- Volume :
- 296
- Database :
- OpenAIRE
- Journal :
- American Journal of Physiology-Cell Physiology
- Accession number :
- edsair.doi.dedup.....7642733559affe50727fb7255a0b04fa
- Full Text :
- https://doi.org/10.1152/ajpcell.00105.2009